Chemists have discovered for the first time a unique way to control and modify a type of compound widely used in medicines, including a drug used to treat breast cancer.

A new study led by Colorado State University Distinguished Professor Eugene Chen outlines a path to creating advanced, recyclable plastics. Published in Nature, the study describes a breakthrough method for upconverting a natural polymer that is usually made by microorganisms into a wide range of new and more sustainable high-performance materials as well as valuable chiral small molecules for organic and polymer synthesis.

Professor Lei Ren’s team has proposed ProcessFM, the first foundational model framework tailored for the process industry. ProcessFM integrates data, mechanisms, knowledge, and computation across four systematic layers. It is designed to address industrial challenges through six core capabilities, enabling trustworthy and intelligent solution for manufacturing industry.

A highly multi-disciplinary research team at the Wyss Institute has made a significant breakthrough to help patients with Rett syndrombe by leveraging an AI-driven drug discovery process in combination with innovative disease modeling. Their study identified a drug known as vorinostat as a promising treatment for Rett syndrome, demonstrating disease-modifying abilities across multiple neuronal and non-neuronal tissues in preclinical models. The Wyss-enabled startup Unravel will be initiating a clinical trial to assess the drug in female patients with Rett syndrome later this year.